| 000 | 01638 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515120755.0 | ||
| 264 | 0 | _c20090716 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1016-8478 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPan, Ying | |
| 245 | 0 | 0 |
_aCurcumin alleviates dystrophic muscle pathology in mdx mice. _h[electronic resource] |
| 260 |
_bMolecules and cells _cJun 2008 |
||
| 300 |
_a531-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aCreatine Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aInterleukin-1beta _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred mdx |
| 650 | 0 | 4 |
_aMuscle Strength _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xpathology |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Animal _xdrug therapy |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhytotherapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aChen, Chen | |
| 700 | 1 | _aShen, Yue | |
| 700 | 1 | _aZhu, Chun-Hua | |
| 700 | 1 | _aWang, Gang | |
| 700 | 1 | _aWang, Xiao-Chun | |
| 700 | 1 | _aChen, Hua-Qun | |
| 700 | 1 | _aZhu, Min-Sheng | |
| 773 | 0 |
_tMolecules and cells _gvol. 25 _gno. 4 _gp. 531-7 |
|
| 999 |
_c17956579 _d17956579 |
||